MY185086A - Human anti-b7rp1 neutralizing antibodies - Google Patents

Human anti-b7rp1 neutralizing antibodies

Info

Publication number
MY185086A
MY185086A MYPI2014000759A MYPI2014000759A MY185086A MY 185086 A MY185086 A MY 185086A MY PI2014000759 A MYPI2014000759 A MY PI2014000759A MY PI2014000759 A MYPI2014000759 A MY PI2014000759A MY 185086 A MY185086 A MY 185086A
Authority
MY
Malaysia
Prior art keywords
b7rp1
antibodies
neutralizing antibodies
human anti
bind
Prior art date
Application number
MYPI2014000759A
Inventor
Huang Haichun
Siu Gerald
Shen Wenyan
Kiyoshi Yoshinaga Steven
Original Assignee
Medarex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medarex Llc filed Critical Medarex Llc
Priority to MYPI2014000759A priority Critical patent/MY185086A/en
Publication of MY185086A publication Critical patent/MY185086A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and method for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
MYPI2014000759A 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies MY185086A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2014000759A MY185086A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2014000759A MY185086A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Publications (1)

Publication Number Publication Date
MY185086A true MY185086A (en) 2021-04-30

Family

ID=81330084

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014000759A MY185086A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Country Status (1)

Country Link
MY (1) MY185086A (en)

Similar Documents

Publication Publication Date Title
SG164369A1 (en) Human anti-b7rp1 neutralizing antibodies
MTP4289B (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MX338754B (en) HUMAN ANTIBODIES AGAINST TISSULAR FACTOR.
MX350200B (en) Human antibodies and antibody-drug conjugates against cd74.
EA201270815A1 (en) ESTROGEN RECEPTOR MODULATORS AND THEIR APPLICATION
UA118332C2 (en) Cs27l antigen binding proteins
MY166776A (en) Humanised anti-ctla4 antibodies
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
WO2008025020A3 (en) Cd30 binding agents and uses thereof
UA92505C2 (en) Anti-cd3 antibody formulations
WO2010008831A3 (en) Compounds and methods for modulating g protein-coupled receptors
UA106529C2 (en) CXCR4 HUMANIZED ANTIBODY FOR CANCER TREATMENT
EA201070636A1 (en) INHIBITION OF THE PROTECTOR PROTEIN, STIMULATING MACROPHAGE (RON), AND METHODS OF ITS TREATMENT
WO2009082038A3 (en) Ampa receptor antagonists and zonisamide for epilepsy
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
WO2009142738A3 (en) Compositions and methods for diagnosing and treating cancer
WO2009020933A3 (en) Therapeutic use of anti-tweak receptor antibodies
WO2007100664A3 (en) Modulators of muscarinic receptors
WO2011025978A3 (en) Methods of treatment using anti-oxidized ldl antibodies
MY152169A (en) Human anti-b7rp1 neutralizing antibodies
WO2008118324A3 (en) Composition and method of treating cancer with an anti-uroplakin ib antibody
UA97645C2 (en) Antibody which binds human il-6 receptor
UA104144C2 (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
UA109423C2 (en) COMPOSITION AND METHOD FOR TUMOR DIAGNOSTICS AND TREATMENT
WO2013158698A3 (en) Method treating scleroderma